Daniel M. Canafax

3.1k total citations
86 papers, 2.5k citations indexed

About

Daniel M. Canafax is a scholar working on Transplantation, Pharmacology and Epidemiology. According to data from OpenAlex, Daniel M. Canafax has authored 86 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Transplantation, 19 papers in Pharmacology and 19 papers in Epidemiology. Recurrent topics in Daniel M. Canafax's work include Renal Transplantation Outcomes and Treatments (24 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Daniel M. Canafax is often cited by papers focused on Renal Transplantation Outcomes and Treatments (24 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Daniel M. Canafax collaborates with scholars based in United States, Canada and Germany. Daniel M. Canafax's co-authors include G. Scott Giebink, Arthur J. Matas, Richard L. Simmons, John S. Najarian, David E.R. Sutherland, Gary R. Erdmann, William D. Payne, Robert J. Cipolle, Nancy L. Ascher and David S. Fryd and has published in prestigious journals such as Circulation, Blood and Gastroenterology.

In The Last Decade

Daniel M. Canafax

84 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel M. Canafax United States 26 689 681 491 384 373 86 2.5k
Philip D. Walson United States 33 447 0.6× 578 0.8× 668 1.4× 255 0.7× 314 0.8× 147 3.3k
Marja P. van Dieijen‐Visser Netherlands 33 292 0.4× 117 0.2× 710 1.4× 121 0.3× 720 1.9× 103 3.3k
Mario Regazzi Italy 36 631 0.9× 290 0.4× 411 0.8× 252 0.7× 194 0.5× 136 3.6k
Yves Théorêt Canada 23 515 0.7× 135 0.2× 312 0.6× 1.1k 3.0× 150 0.4× 111 2.8k
Karen Geboes Belgium 28 1.0k 1.5× 103 0.2× 1.3k 2.6× 508 1.3× 410 1.1× 137 4.0k
David H. Van Thiel United States 40 1.7k 2.5× 698 1.0× 3.3k 6.7× 392 1.0× 463 1.2× 128 5.5k
Brenda C. M. de Winter Netherlands 29 316 0.5× 1.1k 1.6× 376 0.8× 200 0.5× 139 0.4× 130 2.2k
Kathleen D. Lake United States 23 489 0.7× 881 1.3× 686 1.4× 255 0.7× 96 0.3× 66 2.0k
Pascal Crenn France 23 255 0.4× 47 0.1× 959 2.0× 75 0.2× 884 2.4× 77 3.3k
Domênico Capone Italy 27 978 1.4× 169 0.2× 311 0.6× 100 0.3× 231 0.6× 108 2.5k

Countries citing papers authored by Daniel M. Canafax

Since Specialization
Citations

This map shows the geographic impact of Daniel M. Canafax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Canafax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Canafax more than expected).

Fields of papers citing papers by Daniel M. Canafax

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Canafax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Canafax. The network helps show where Daniel M. Canafax may publish in the future.

Co-authorship network of co-authors of Daniel M. Canafax

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Canafax. A scholar is included among the top collaborators of Daniel M. Canafax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Canafax. Daniel M. Canafax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mason, Jay W., et al.. (2014). Electrocardiographic and cardiovascular diagnostic characteristics of patients receiving long-term opioid therapy for pain. Journal of Opioid Management. 10(2). 103–109. 4 indexed citations
2.
Ezekowitz, Michael D., Rangadham Nagarakanti, Andrzej Lubiński, et al.. (2011). A randomized trial of budiodarone in paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 34(1). 1–9. 19 indexed citations
3.
4.
Bavisotto, Linda M., David Ellis, Peter G. Milner, et al.. (2010). Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants. The Journal of Clinical Pharmacology. 51(4). 561–574. 23 indexed citations
5.
Cundy, Kenneth C., et al.. (2008). Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin. The Journal of Clinical Pharmacology. 48(12). 1378–1388. 93 indexed citations
6.
Meier‐Kriesche, Herwig‐Ulf, Rita R. Alloway, Ahmed Osama, et al.. (1999). A Limited Sampling Strategy for the Estimation of 12‐Hour SangCya and Neoral AUCs in Renal Transplant Recipients. The Journal of Clinical Pharmacology. 39(2). 166–171. 10 indexed citations
7.
Canafax, Daniel M., et al.. (1998). Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. The Pediatric Infectious Disease Journal. 17(2). 149–156. 71 indexed citations
8.
Zhi, Yuan, et al.. (1995). Sensitive assay for measuring amoxicillin in human plasma and middle ear fluid using solid-phase extraction and reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 674(1). 93–99. 26 indexed citations
9.
Granger, Darla K., John W. Cromwell, Joseph J. Goswitz, et al.. (1995). Prolongation Of Renal Allograft Survival In A Large Animal Model By Oral Rapamycin Monotherapy. Transplantation. 59(2). 183–186. 4 indexed citations
10.
Lovdahl, Michael, et al.. (1994). Determination of cefpodoxime levels in chinchilla middle ear fluid and plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 653(2). 227–232. 13 indexed citations
11.
Canafax, Daniel M., et al.. (1994). Comparison of Two Otitis Media Models for the Study of Middle Ear Antimicrobial Pharmacokinetics. Pharmaceutical Research. 11(6). 855–859. 8 indexed citations
12.
Lovdahl, Michael, et al.. (1993). Determination of ciprofloxacin levels in chinchilla middle ear effusion and plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 617(2). 329–333. 19 indexed citations
13.
Almond, P. Stephen, Arthur J. Matas, & Daniel M. Canafax. (1991). Fixed‐Rate Reimbursement Fails to Cover Costs for Patients with Delayed Graft Function. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 11(5). 126S–129S. 21 indexed citations
14.
Erdmann, Gary R., et al.. (1991). Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguanine in humans. Journal of Chromatography B Biomedical Sciences and Applications. 571(1-2). 149–156. 20 indexed citations
15.
16.
Canafax, Daniel M., et al.. (1989). Experimental Animal Models for Studying Antimicrobial Pharmacokinetics in Otitis Media. Pharmaceutical Research. 6(4). 279–285. 34 indexed citations
17.
Erdmann, Gary R., et al.. (1989). Determination of mizoribine in plasma using ion-pair high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 494. 354–360. 2 indexed citations
18.
Cipolle, Robert J., et al.. (1988). Time‐Dependent Disposition of Cyclosporine after Pancreas Transplantation, and Application of Chronopharmacokinetics to Improve Immunosuppression. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 8(1). 47–51. 20 indexed citations
19.
Fryd, David S., Samuel So, Raafat Seifeldin, et al.. (1987). Improving results of renal transplantation with multidrug therapy in patients over 50 years of age. Clinical Transplantation. 1(2). 75–80. 6 indexed citations
20.
Chan, Gary L. C., Daniel M. Canafax, & Curtis A. Johnson. (1987). The Therapeutic Use of Azathioprine in Renal Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 7(5). 165–177. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip D. Walson Breakdown of academic impact, for papers by Marja P. van Dieijen‐Visser Breakdown of academic impact, for papers by Mario Regazzi Breakdown of academic impact, for papers by Yves Théorêt Breakdown of academic impact, for papers by Karen Geboes Breakdown of academic impact, for papers by David H. Van Thiel Breakdown of academic impact, for papers by Brenda C. M. de Winter Breakdown of academic impact, for papers by Kathleen D. Lake Breakdown of academic impact, for papers by Pascal Crenn Breakdown of academic impact, for papers by Domênico Capone
Rankless by CCL
2026